FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007231330> ?p ?o ?g. }

• W2007231330 endingPage "139" @default.
• W2007231330 startingPage "139" @default.
• W2007231330 abstract "Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy Søren Pauli Bro,1 Maiken Ina Siegismund Kjaersgaard,2 Erik Thorlund Parner,2 Merete Juul Sørensen,3 Jørn Olsen,4 Bodil Hammer Bech,4 Lars Henning Pedersen,4,5 Jakob Christensen,6,7 Mogens Vestergaard11Research Unit and Section for General Practice, Department of Public Health, 2Section for Biostatistics, Department of Public Health, Aarhus University, 3Regional Center for Child and Adolescent Psychiatry, Aarhus University Hospital, 4Section for Epidemiology, Department of Public Health, 5Department of Clinical Medicine – Obstetrics and Gynecology, Aarhus University, 6Department of Clinical Pharmacology, 7Department of Neurology, Aarhus University Hospital, Aarhus, DenmarkObjective: To determine if prenatal exposure to methylphenidate (MPH) or atomoxetine (ATX) increases the risk of adverse pregnancy outcomes in women with attention deficit/hyperactivity disorder (ADHD).Materials and methods: This was a population-based cohort study of all pregnancies in Denmark from 1997 to 2008. Information on use of ADHD medication, ADHD diagnosis, and pregnancy outcomes was obtained from nationwide registers.Results: We identified 989,932 pregnancies, in which 186 (0.02%) women used MPH/ATX and 275 (0.03%) women had been diagnosed with ADHD but who did not take MPH/ATX. Our reference pregnancies had no exposure to MPH/ATX and no ADHD diagnosis. Exposure to MPH/ATX was associated with an increased risk of spontaneous abortion (SA; ie, death of an embryo or fetus in the first 22 weeks of gestation) (adjusted relative risk [aRR] 1.55, 95% confidence interval [CI] 1.03–2.36). The risk of SA was also increased in pregnancies where the mother had ADHD but did not use MPH/ATX (aRR 1.56, 95% CI 1.11–2.20). The aRR of Apgar scores <10 was increased among exposed women (aRR 2.06, 95% CI 1.11–3.82) but not among unexposed women with ADHD (aRR 0.99, 95% CI 0.48–2.05).Conclusion: MPH/ATX was associated with a higher risk of SA, but our study indicated that it may at least partly be explained by confounding by indication. Treatment with MPH/ATX was however associated with low Apgar scores <10, an association not found among women with ADHD who did not use MPH/ATX.Keywords: attention deficit/hyperactivity disorder, ADHD, methylphenidate, atomoxetine, pregnancy outcomes" @default.
• W2007231330 created "2016-06-24" @default.
• W2007231330 creator A5006842273 @default.
• W2007231330 creator A5017926592 @default.
• W2007231330 creator A5020981760 @default.
• W2007231330 creator A5038510300 @default.
• W2007231330 creator A5064314944 @default.
• W2007231330 creator A5066364837 @default.
• W2007231330 creator A5075546065 @default.
• W2007231330 creator A5076104796 @default.
• W2007231330 creator A5079273028 @default.
• W2007231330 date "2015-01-01" @default.
• W2007231330 modified "2023-10-02" @default.
• W2007231330 title "Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy" @default.
• W2007231330 cites W1937522003 @default.
• W2007231330 cites W1984107436 @default.
• W2007231330 cites W1992062274 @default.
• W2007231330 cites W1997430300 @default.
• W2007231330 cites W2006549096 @default.
• W2007231330 cites W2009496531 @default.
• W2007231330 cites W2027281777 @default.
• W2007231330 cites W2027861707 @default.
• W2007231330 cites W2029263339 @default.
• W2007231330 cites W2031419915 @default.
• W2007231330 cites W2036040382 @default.
• W2007231330 cites W2037668591 @default.
• W2007231330 cites W2038797528 @default.
• W2007231330 cites W2048127038 @default.
• W2007231330 cites W2050439553 @default.
• W2007231330 cites W2051493707 @default.
• W2007231330 cites W2052387693 @default.
• W2007231330 cites W2103445055 @default.
• W2007231330 cites W2126271209 @default.
• W2007231330 cites W2130373985 @default.
• W2007231330 cites W2135680338 @default.
• W2007231330 cites W2155350946 @default.
• W2007231330 cites W2312865146 @default.
• W2007231330 cites W4245201616 @default.
• W2007231330 doi "https://doi.org/10.2147/clep.s72906" @default.
• W2007231330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4317061" @default.
• W2007231330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25657597" @default.
• W2007231330 hasPublicationYear "2015" @default.
• W2007231330 type Work @default.
• W2007231330 sameAs 2007231330 @default.
• W2007231330 citedByCount "38" @default.
• W2007231330 countsByYear W20072313302016 @default.
• W2007231330 countsByYear W20072313302017 @default.
• W2007231330 countsByYear W20072313302018 @default.
• W2007231330 countsByYear W20072313302019 @default.
• W2007231330 countsByYear W20072313302020 @default.
• W2007231330 countsByYear W20072313302021 @default.
• W2007231330 countsByYear W20072313302022 @default.
• W2007231330 countsByYear W20072313302023 @default.
• W2007231330 crossrefType "journal-article" @default.
• W2007231330 hasAuthorship W2007231330A5006842273 @default.
• W2007231330 hasAuthorship W2007231330A5017926592 @default.
• W2007231330 hasAuthorship W2007231330A5020981760 @default.
• W2007231330 hasAuthorship W2007231330A5038510300 @default.
• W2007231330 hasAuthorship W2007231330A5064314944 @default.
• W2007231330 hasAuthorship W2007231330A5066364837 @default.
• W2007231330 hasAuthorship W2007231330A5075546065 @default.
• W2007231330 hasAuthorship W2007231330A5076104796 @default.
• W2007231330 hasAuthorship W2007231330A5079273028 @default.
• W2007231330 hasBestOaLocation W20072313301 @default.
• W2007231330 hasConcept C118552586 @default.
• W2007231330 hasConcept C131872663 @default.
• W2007231330 hasConcept C187212893 @default.
• W2007231330 hasConcept C2777112843 @default.
• W2007231330 hasConcept C2778642596 @default.
• W2007231330 hasConcept C2778781522 @default.
• W2007231330 hasConcept C2779234561 @default.
• W2007231330 hasConcept C2780783007 @default.
• W2007231330 hasConcept C29456083 @default.
• W2007231330 hasConcept C54355233 @default.
• W2007231330 hasConcept C71924100 @default.
• W2007231330 hasConcept C86803240 @default.
• W2007231330 hasConceptScore W2007231330C118552586 @default.
• W2007231330 hasConceptScore W2007231330C131872663 @default.
• W2007231330 hasConceptScore W2007231330C187212893 @default.
• W2007231330 hasConceptScore W2007231330C2777112843 @default.
• W2007231330 hasConceptScore W2007231330C2778642596 @default.
• W2007231330 hasConceptScore W2007231330C2778781522 @default.
• W2007231330 hasConceptScore W2007231330C2779234561 @default.
• W2007231330 hasConceptScore W2007231330C2780783007 @default.
• W2007231330 hasConceptScore W2007231330C29456083 @default.
• W2007231330 hasConceptScore W2007231330C54355233 @default.
• W2007231330 hasConceptScore W2007231330C71924100 @default.
• W2007231330 hasConceptScore W2007231330C86803240 @default.
• W2007231330 hasLocation W20072313301 @default.
• W2007231330 hasLocation W20072313302 @default.
• W2007231330 hasLocation W20072313303 @default.
• W2007231330 hasLocation W20072313304 @default.
• W2007231330 hasOpenAccess W2007231330 @default.
• W2007231330 hasPrimaryLocation W20072313301 @default.
• W2007231330 hasRelatedWork W1599807686 @default.
• W2007231330 hasRelatedWork W1975343712 @default.
• W2007231330 hasRelatedWork W1990984202 @default.
• W2007231330 hasRelatedWork W1991441238 @default.

• next